Inside the research

Balchem Corporation

BCPC Research profile · latest available data

Price overview

$167.89

▲ +0.05 (+0.0%)

52w hi$183.26
52w lo$139.44
Vol212.50K
As of25 Sep 2026

The Verdict

Hold

Our score -0.13

Short-0.11
Medium-0.18
Long-0.08

computed 2026-09-27

Key fundamentals

Balchem Corporation

Basic Materials · Specialty Chemicals

Market cap$5.35B
Enterprise value$5.46B
Trailing P/E32.98x
Forward P/E26.77x
EV / EBITDA20.25x
P / S (ttm)4.93x
Profit margin15.1%
Return on equity12.8%
Revenue growth+11.2%
Earnings growth+18.8%
Debt / equity12.80

Layer Breakdown

LayerRawContribution
Fundamental+0.23
Sector-0.02
Technical-0.12
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

United States · www.balchem.com

Risk Metrics

Beta vs SPX0.49
Corr SPX0.36
Annual vol21.6%
Annual ret+0.3%
Sharpe0.02
Max DD-23.5%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-07-31Earnings Release, Exhibitsread
2026-07-27Material Agreement, Material Obligation…read
2026-06-22Shareholder Voteread
2026-04-30Earnings Release, Exhibitsread
2026-02-20Earnings Release, Exhibitsread
2026-02-19Officer / Director Change, Exhibitsread
2025-12-10Reg FD Disclosure, Exhibitsread
2025-10-21Earnings Release, Exhibitsread
2025-07-31Earnings Release, Exhibitsread
2025-06-20Shareholder Voteread
2025-04-24Earnings Release, Exhibitsread
2025-03-03Officer / Director Change, Exhibitsread

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders9
Top-5 share94.0%
HHI3,428 (concentrated)

Top Holders

HolderValueShares
State Street Corp$216.52M1.28M
Fidelity / FMR LLC$94.66M560.25K
Renaissance Technologies$32.66M193.30K
Millennium Management$31.18M184.56K
AQR Capital Management$12.58M74.43K
Citadel Advisors$12.51M74.02K
Capital Research / Capital World$9.95M58.92K
Bridgewater Associates$2.27M13.42K
T. Rowe Price Group$18.82K111.37K

As of 2026-06-30

Dividends

Yield (TTM)0.57%
$ / share (TTM)$0.96
5y CAGR+10.6%

Annual dividend per share

2020$0.58
2021$0.64
2022$0.71
2023$0.79
2024$0.87
2025$0.96

SEC Filings

DateFormDoc
2026-07-318-Kview
2026-07-3110-Qview
2026-07-278-Kview
2026-06-228-Kview
2026-06-1811-Kview
2026-04-308-Kview
2026-04-3010-Qview
2026-04-27DEFA14Aview
2026-04-27DEF 14Aview
2026-04-073view
2026-02-2010-Kview
2026-02-208-Kview
2026-02-198-Kview
2026-02-134view
2026-02-134view

The Long Run

FY 2011–2025 · 15 years

LineLatestCAGRTrend
Revenue$234.08M+8.7%
Gross profit$93.11M+2.4%
Operating income$182.91M+8.8%
Net income$108.54M+7.6%
Cash from ops$183.76M+13.0%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$167.41$168.59$166.01$167.89212.50K
Sep 24$168.94$169.16$166.91$167.84159.40K
Sep 23$167.65$169.51$167.65$168.24145.60K
Sep 22$169.58$170.62$167.99$168.40217.00K
Sep 21$167.73$168.34$166.08$167.34199.00K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →